サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1225450

アフェレシス市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年の予測

Apheresis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 148 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.85円
アフェレシス市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年の予測
出版日: 2023年02月03日
発行: IMARC
ページ情報: 英文 148 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場概要

  • 世界のアフェレシス市場規模は、2022年に27億米ドルに達しました。今後、IMARCグループは、2023年から2028年の間に7.55%の成長率（CAGR）を示し、2028年までに43億米ドルに達すると予測しています。
  • アフェレシスとは、赤血球（RBC）、白血球（WBC）、血小板、血漿など、提供された血液成分を分離し、様々な疾患の治療に用いる手法のことです。赤血球（RBC）の形が異常で、体内で酸素を運ぶことができない鎌状赤血球症の治療を支援します。また、血液を濃くして臓器機能を阻害する異常な白血球（WBC）を除去するためにも使用されます。さらに、血液がんや重症筋無力症、血栓性血小板減少性紫斑病（TTP）などの血液疾患の治療にも役立つため、アフェレシスは世界中の採血センター、病院、外来センターで広く使用されています。

アフェレシス市場動向

  • 自己免疫性溶血性貧血、急性散在性脳脊髄炎、心性新生児ループスなど、さまざまな疾患の治療のためにアフェレシスに対する需要が高まっていることが、市場を牽引する重要な要因の一つとなっています。このほか、火傷や外傷の患者の治療のために血漿を採取するアフェレーシスの利用が世界的に増加しています。このことは、ヘルスケア産業の急成長とともに、市場の成長に寄与しています。さらに、重症の閉塞性動脈硬化症を治療する強化された血液浄化装置を導入するための研究開発活動への主な市場プレイヤーの投資の増加が、市場にプラスの影響を及ぼしています。さらに、原発性免疫不全症や血友病を治療するための原血漿の需要の高まりは、業界の投資家に有利な成長機会を提供しています。これとは別に、血栓性血小板減少性紫斑病、溶血性尿毒症症候群、薬物毒性、自己免疫疾患、敗血症、劇症肝不全などのさまざまな疾患の治療法としてアフェレシス採用が拡大しており、市場の前向きな見通しを示しています。その他の特典として、アフェレシスの利点に関する大衆の認識が高まっていることが、市場の成長を後押ししています。

主な市場セグメンテーション

  • IMARC Groupは、世界のアフェレシス市場レポートの各サブセグメントにおける主要動向の分析を、2023年から2028年までの世界、地域、国レベルでの予測とともに提供しています。当レポートでは、構成要素、製品、技術、手順、用途、エンドユーザーに基づいて市場を分類しています。

構成要素別の内訳

  • 血漿（プラズマフェレーシス）
  • 血小板（プラトレットフェレーシス）
  • 白血球（ロイカフェレーシスまたはロイコフェレーシス）
  • リンパ球（リンパフェレーシスまたはリンパ球）
  • 赤血球（赤沈）（Erythropheresis

製品別の内訳

  • デバイス
  • 消耗品・試薬
  • ソフトウェア

技術別の内訳

  • 遠心分離
  • 膜分離
  • 選択的吸着

処置別内訳

  • ドナー/自動アフェレシス
  • 治療用アフェレシス

用途別内訳

  • 腎臓疾患
  • 血液疾患
  • 神経系疾患
  • 自己免疫疾患
  • その他

エンドユーザー別の内訳

  • 血液センター
  • 病院
  • その他

地域別の内訳

  • 北米
  • 米国
  • カナダ
  • アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
  • 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
  • ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
  • 中東とアフリカ

本レポートで回答した主な質問

  • 世界のアフェレシス市場はこれまでどのように推移し、今後どのように推移していくのか？
  • COVID-19は世界のアフェレシス市場にどのような影響を与えたか？
  • 主要な地域別市場とは？
  • 構成要素に基づく市場内訳は？
  • 製品別の市場内訳は？
  • 技術別の市場内訳は？
  • 処置別の市場内訳は？
  • 用途別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 業界のバリューチェーンにおける様々なステージとは？
  • 業界における主要な促進要因と課題は何か？
  • 世界のアフェレシス市場の構造、主要プレイヤーは？
  • 業界における競合の度合いとは？

目次

第1章 序文

第2章 調査手法と範囲

  • 調査の目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要な産業動向

第5章 アフェレシスの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 構成要素別市場内訳

  • 血漿（プラズマフェレーシス）
    • 市場動向
    • 市場展望
  • 血小板（プラトレットフェレーシス）
    • 市場動向
    • 市場展望
  • 白血球（ロイカフェレーシス、ロイコフェレーシス）
    • 市場動向
    • 市場展望
  • リンパ球（リンパフェレーシス、Lymphapheresis）
    • 市場動向
    • 市場予測
  • 赤血球（赤沈）（Erythropheresis）
    • 市場動向
    • 市場予測

第7章 製品別市場内訳

  • デバイス
    • 市場動向
    • 市場予測
  • ディスポーザブル・試薬
    • 市場動向
    • 市場予測
  • ソフトウェア
    • 市場動向
    • 市場予測

第8章 技術別市場内訳

  • 遠心分離機
    • 市場動向
    • 市場展望
  • 膜分離
    • 市場動向
    • 市場予測
  • 選択的吸着
    • 市場動向
    • 市場展望

第9章 処置別市場内訳

  • ドナー/自動アフェレシス
    • 市場動向
    • 市場予測
  • 治療用アフェレシス
    • 市場動向
    • 市場予測

第10章 用途別市場内訳

  • 腎臓疾患
    • 市場動向
    • 市場展望
  • 血液疾患
    • 市場動向
    • 市場予測
  • 神経疾患
    • 市場動向
    • 市場展望
  • 自己免疫疾患
    • 市場動向
    • 市場展望
  • その他
    • 市場動向
    • 市場予測

第11章 エンドユーザー別市場内訳

  • 血液センター
    • 市場動向
    • 市場予測
  • 病院
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第12章 地域別市場内訳

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場展望
  • アジア太平洋地域
    • 中国
      • 市場動向
      • 市場展望
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場展望
    • 韓国市場
      • 市場動向
      • 市場展望
    • オーストラリア
      • 市場動向
      • 市場展望
    • インドネシア
      • 市場動向
      • 市場展望
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場展望
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場展望
    • スペイン
      • 市場動向
      • 市場展望
    • ロシア
      • 市場動向
      • 市場展望
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場展望
    • メキシコ
      • 市場動向
      • 市場展望
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 国別市場内訳
    • 市場展望

第13章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第14章 バリューチェーン分析

第15章 ポーターズファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の度合い
  • 新規参入業者の脅威
  • 代替品の脅威

第16章 価格分析

第17章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Asahi Kasei Medical Co. Ltd.（Asahi Kasei Corporation）
    • B. Braun SE
    • Charles River Laboratories International Inc.
    • Fresenius Medical Care AG & Co. KGaA
    • Haemonetics Corporation
    • Haier Biomedical
    • Kaneka Corporation
    • Medica S.p.a.
    • Miltenyi Biotec
    • Nikkiso Co. Ltd.
    • Sb-Kawasumi Laboratories Inc.（Sumitomo Bakelite Company Limited）
    • Terumo Bct Inc.（Terumo Corporation）
図表

List of Figures

  • Figure 1: Global: Apheresis Market: Major Drivers and Challenges
  • Figure 2: Global: Apheresis Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Apheresis Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Apheresis Market: Breakup by Component (in %), 2022
  • Figure 5: Global: Apheresis Market: Breakup by Product (in %), 2022
  • Figure 6: Global: Apheresis Market: Breakup by Technology (in %), 2022
  • Figure 7: Global: Apheresis Market: Breakup by Procedure (in %), 2022
  • Figure 8: Global: Apheresis Market: Breakup by Application (in %), 2022
  • Figure 9: Global: Apheresis Market: Breakup by End User (in %), 2022
  • Figure 10: Global: Apheresis Market: Breakup by Region (in %), 2022
  • Figure 11: Global: Apheresis (Plasma (Plasmapheresis)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Apheresis (Plasma (Plasmapheresis)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Apheresis (Platelets (Plateletpheresis)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Apheresis (Platelets (Plateletpheresis)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Apheresis (Leukocytes (Leukapheresis or Leukopheresis)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Apheresis (Leukocytes (Leukapheresis or Leukopheresis)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Apheresis (Lymphocytes (Lymphopheresis or Lymphapheresis)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Apheresis (Lymphocytes (Lymphopheresis or Lymphapheresis)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Apheresis (RBC's (Erythropheresis)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Apheresis (RBC's (Erythropheresis)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Apheresis (Devices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Apheresis (Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Apheresis (Disposables and Reagents) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Apheresis (Disposables and Reagents) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Apheresis (Software) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Apheresis (Software) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Apheresis (Centrifugation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Apheresis (Centrifugation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Apheresis (Membrane Separation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Apheresis (Membrane Separation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Apheresis (Selective Adsorption) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Apheresis (Selective Adsorption) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Apheresis (Donor/Automated Apheresis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Apheresis (Donor/Automated Apheresis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Apheresis (Therapeutic Apheresis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Apheresis (Therapeutic Apheresis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Apheresis (Renal Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Apheresis (Renal Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Apheresis (Hematological Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Apheresis (Hematological Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Global: Apheresis (Neurological Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Global: Apheresis (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Global: Apheresis (Autoimmune Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Global: Apheresis (Autoimmune Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Global: Apheresis (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Global: Apheresis (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Global: Apheresis (Blood Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Global: Apheresis (Blood Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Global: Apheresis (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Global: Apheresis (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Global: Apheresis (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Global: Apheresis (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: North America: Apheresis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: North America: Apheresis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: United States: Apheresis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: United States: Apheresis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Canada: Apheresis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Canada: Apheresis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Asia-Pacific: Apheresis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Asia-Pacific: Apheresis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: China: Apheresis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: China: Apheresis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Japan: Apheresis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Japan: Apheresis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: India: Apheresis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: India: Apheresis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: South Korea: Apheresis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: South Korea: Apheresis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Australia: Apheresis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Australia: Apheresis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Indonesia: Apheresis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Indonesia: Apheresis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Others: Apheresis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Others: Apheresis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Europe: Apheresis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Europe: Apheresis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Germany: Apheresis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Germany: Apheresis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: France: Apheresis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: France: Apheresis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: United Kingdom: Apheresis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: United Kingdom: Apheresis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Italy: Apheresis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Italy: Apheresis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Spain: Apheresis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Spain: Apheresis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Russia: Apheresis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Russia: Apheresis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Others: Apheresis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 90: Others: Apheresis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 91: Latin America: Apheresis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 92: Latin America: Apheresis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 93: Brazil: Apheresis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 94: Brazil: Apheresis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 95: Mexico: Apheresis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 96: Mexico: Apheresis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 97: Others: Apheresis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 98: Others: Apheresis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 99: Middle East and Africa: Apheresis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 100: Middle East and Africa: Apheresis Market: Breakup by Country (in %), 2022
  • Figure 101: Middle East and Africa: Apheresis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 102: Global: Apheresis Industry: SWOT Analysis
  • Figure 103: Global: Apheresis Industry: Value Chain Analysis
  • Figure 104: Global: Apheresis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Apheresis Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Apheresis Market Forecast: Breakup by Component (in Million US$), 2023-2028
  • Table 3: Global: Apheresis Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 4: Global: Apheresis Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 5: Global: Apheresis Market Forecast: Breakup by Procedure (in Million US$), 2023-2028
  • Table 6: Global: Apheresis Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 7: Global: Apheresis Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 8: Global: Apheresis Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 9: Global: Apheresis Market: Competitive Structure
  • Table 10: Global: Apheresis Market: Key Players
目次
Product Code: SR1423A291_Report

Market Overview:

  • The global apheresis market size reached US$ 2.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.3 Billion by 2028, exhibiting a growth rate (CAGR) of 7.55% during 2023-2028.
  • Apheresis is a procedure of separating donated blood components, such as red blood cells (RBCs), white blood cells (WBCs), platelets, and plasma, to treat various diseases. It assists in treating sickle cell disease wherein red blood cells (RBCs) are shaped abnormally and cannot carry oxygen through the body. It is also employed to remove abnormal white blood cells (WBCs) that thicken the blood and interfere with organ function. In addition, as it aids in treating blood cancers and blood disorders, such as myasthenia gravis and thrombotic thrombocytopenic purpura (TTP), apheresis is widely used in blood collection centers, hospitals, and ambulatory centers across the globe.

Apheresis Market Trends:

  • The growing demand for apheresis to treat various diseases, such as autoimmune hemolytic anemia, acute disseminated encephalomyelitis, and cardiac neonatal lupus, represents one of the key factors driving the market. Besides this, there is a rise in the utilization of apheresis to collect plasma for treating burnt and trauma patients across the globe. This, along with the burgeoning healthcare industry, is contributing to the growth of the market. Moreover, increasing investments by key market players in research and development (R&D) activities to introduce an enhanced blood purification device that treats severe forms of arteriosclerosis obliterans is positively influencing the market. In addition, the rising demand for source plasma to treat primary immunodeficiency and hemophilia is offering lucrative growth opportunities to industry investors. Apart from this, the growing employment of apheresis as a therapy for various diseases, such as thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, drug toxicities, autoimmune disease, sepsis, and fulminant hepatic failure, is offering a positive market outlook. Additionally, the increasing awareness among the masses about the benefits of apheresis is bolstering the growth of the market.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global apheresis market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on component, product, technology, procedure, application and end user.

Breakup by Component:

  • Plasma (Plasmapheresis)
  • Platelets (Plateletpheresis)
  • Leukocytes (Leukapheresis or Leukopheresis)
  • Lymphocytes (Lymphopheresis or Lymphapheresis)
  • RBC's (Erythropheresis)

Breakup by Product:

  • Devices
  • Disposables and Reagents
  • Software

Breakup by Technology:

  • Centrifugation
  • Membrane Separation
  • Selective Adsorption

Breakup by Procedure:

  • Donor/Automated Apheresis
  • Therapeutic Apheresis

Breakup by Application:

  • Renal Disorders
  • Hematological Disorders
  • Neurological Disorders
  • Autoimmune Disorders
  • Others

Breakup by End User:

  • Blood Centers
  • Hospitals
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined along with the profiles of the key players being Asahi Kasei Medical Co. Ltd. (Asahi Kasei Corporation), B. Braun SE, Charles River Laboratories International Inc., Fresenius Medical Care AG & Co. KGaA, Haemonetics Corporation, Haier Biomedical, Kaneka Corporation, Medica S.p.a., Miltenyi Biotec, Nikkiso Co. Ltd., Sb-Kawasumi Laboratories Inc. (Sumitomo Bakelite Company Limited) and Terumo Bct Inc. (Terumo Corporation).

Key Questions Answered in This Report:

  • How has the global apheresis market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global apheresis market?
  • What are the key regional markets?
  • What is the breakup of the market based on the component?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the procedure?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global apheresis market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Apheresis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Plasma (Plasmapheresis)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Platelets (Plateletpheresis)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Leukocytes (Leukapheresis or Leukopheresis)
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Lymphocytes (Lymphopheresis or Lymphapheresis)
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 RBC's (Erythropheresis)
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Devices
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Disposables and Reagents
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Software
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Centrifugation
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Membrane Separation
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Selective Adsorption
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Procedure

  • 9.1 Donor/Automated Apheresis
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Therapeutic Apheresis
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Application

  • 10.1 Renal Disorders
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hematological Disorders
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Neurological Disorders
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Autoimmune Disorders
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Others
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 Market Breakup by End User

  • 11.1 Blood Centers
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Hospitals
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Others
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast

12 Market Breakup by Region

  • 12.1 North America
    • 12.1.1 United States
      • 12.1.1.1 Market Trends
      • 12.1.1.2 Market Forecast
    • 12.1.2 Canada
      • 12.1.2.1 Market Trends
      • 12.1.2.2 Market Forecast
  • 12.2 Asia-Pacific
    • 12.2.1 China
      • 12.2.1.1 Market Trends
      • 12.2.1.2 Market Forecast
    • 12.2.2 Japan
      • 12.2.2.1 Market Trends
      • 12.2.2.2 Market Forecast
    • 12.2.3 India
      • 12.2.3.1 Market Trends
      • 12.2.3.2 Market Forecast
    • 12.2.4 South Korea
      • 12.2.4.1 Market Trends
      • 12.2.4.2 Market Forecast
    • 12.2.5 Australia
      • 12.2.5.1 Market Trends
      • 12.2.5.2 Market Forecast
    • 12.2.6 Indonesia
      • 12.2.6.1 Market Trends
      • 12.2.6.2 Market Forecast
    • 12.2.7 Others
      • 12.2.7.1 Market Trends
      • 12.2.7.2 Market Forecast
  • 12.3 Europe
    • 12.3.1 Germany
      • 12.3.1.1 Market Trends
      • 12.3.1.2 Market Forecast
    • 12.3.2 France
      • 12.3.2.1 Market Trends
      • 12.3.2.2 Market Forecast
    • 12.3.3 United Kingdom
      • 12.3.3.1 Market Trends
      • 12.3.3.2 Market Forecast
    • 12.3.4 Italy
      • 12.3.4.1 Market Trends
      • 12.3.4.2 Market Forecast
    • 12.3.5 Spain
      • 12.3.5.1 Market Trends
      • 12.3.5.2 Market Forecast
    • 12.3.6 Russia
      • 12.3.6.1 Market Trends
      • 12.3.6.2 Market Forecast
    • 12.3.7 Others
      • 12.3.7.1 Market Trends
      • 12.3.7.2 Market Forecast
  • 12.4 Latin America
    • 12.4.1 Brazil
      • 12.4.1.1 Market Trends
      • 12.4.1.2 Market Forecast
    • 12.4.2 Mexico
      • 12.4.2.1 Market Trends
      • 12.4.2.2 Market Forecast
    • 12.4.3 Others
      • 12.4.3.1 Market Trends
      • 12.4.3.2 Market Forecast
  • 12.5 Middle East and Africa
    • 12.5.1 Market Trends
    • 12.5.2 Market Breakup by Country
    • 12.5.3 Market Forecast

13 SWOT Analysis

  • 13.1 Overview
  • 13.2 Strengths
  • 13.3 Weaknesses
  • 13.4 Opportunities
  • 13.5 Threats

14 Value Chain Analysis

15 Porters Five Forces Analysis

  • 15.1 Overview
  • 15.2 Bargaining Power of Buyers
  • 15.3 Bargaining Power of Suppliers
  • 15.4 Degree of Competition
  • 15.5 Threat of New Entrants
  • 15.6 Threat of Substitutes

16 Price Analysis

17 Competitive Landscape

  • 17.1 Market Structure
  • 17.2 Key Players
  • 17.3 Profiles of Key Players
    • 17.3.1 Asahi Kasei Medical Co. Ltd. (Asahi Kasei Corporation)
      • 17.3.1.1 Company Overview
      • 17.3.1.2 Product Portfolio
    • 17.3.2 B. Braun SE
      • 17.3.2.1 Company Overview
      • 17.3.2.2 Product Portfolio
      • 17.3.2.3 SWOT Analysis
    • 17.3.3 Charles River Laboratories International Inc.
      • 17.3.3.1 Company Overview
      • 17.3.3.2 Product Portfolio
      • 17.3.3.3 Financials
      • 17.3.3.4 SWOT Analysis
    • 17.3.4 Fresenius Medical Care AG & Co. KGaA
      • 17.3.4.1 Company Overview
      • 17.3.4.2 Product Portfolio
      • 17.3.4.3 Financials
      • 17.3.4.4 SWOT Analysis
    • 17.3.5 Haemonetics Corporation
      • 17.3.5.1 Company Overview
      • 17.3.5.2 Product Portfolio
      • 17.3.5.3 Financials
      • 17.3.5.4 SWOT Analysis
    • 17.3.6 Haier Biomedical
      • 17.3.6.1 Company Overview
      • 17.3.6.2 Product Portfolio
    • 17.3.7 Kaneka Corporation
      • 17.3.7.1 Company Overview
      • 17.3.7.2 Product Portfolio
      • 17.3.7.3 Financials
      • 17.3.7.4 SWOT Analysis
    • 17.3.8 Medica S.p.a.
      • 17.3.8.1 Company Overview
      • 17.3.8.2 Product Portfolio
      • 17.3.8.3 Financials
    • 17.3.9 Miltenyi Biotec
      • 17.3.9.1 Company Overview
      • 17.3.9.2 Product Portfolio
    • 17.3.10 Nikkiso Co. Ltd.
      • 17.3.10.1 Company Overview
      • 17.3.10.2 Product Portfolio
      • 17.3.10.3 Financials
      • 17.3.10.4 SWOT Analysis
    • 17.3.11 Sb-Kawasumi Laboratories Inc. (Sumitomo Bakelite Company Limited)
      • 17.3.11.1 Company Overview
      • 17.3.11.2 Product Portfolio
    • 17.3.12 Terumo Bct Inc. (Terumo Corporation)
      • 17.3.12.1 Company Overview
      • 17.3.12.2 Product Portfolio